Some of them have also been linked to human type 1 diabetes raising the possibility of
developing vaccines against these viruses to prevent some of the new cases of type 1 diabetes.
This new discovery, funded by multiple groups, opens up novel possibilities for future research aimed at
developing vaccines against these viruses to prevent type 1 diabetes.
Not exact matches
Because the swine flu
virus was traced on the evolutionary tree to see how it mutated and thus
develop a
vaccine that works
against it.
Horse owners have launched a $ 53 million lawsuit
against the pharmaceutical company responsible for
developing the Hendra
virus vaccine.
The hepatitis B
virus can affect your liver, so it is important to ensure that your baby gets the hepatitis B
vaccine to
develop immunity
against it.
There is only a preliminary form of a
vaccine against H5N1 flu strains, and even if there were a
developed vaccine, the
virus might spread faster than public - health officials could get people inoculated.
When Thomas Monath, an expert on
vaccines combating mosquito - borne diseases, thinks about
developing an inoculation
against Zika
virus, he has a major concern: Guillain — Barré syndrome.
Yet there is reason for optimism: the NIH has already
developed a DNA
vaccine against the West Nile
virus that appeared promising in early human studies (although ultimately the NIH could not find a commercial partner to take that
vaccine forward).
Attempts at using live dengue
viruses to
develop a dengue fever
vaccine have often led to an imbalance in immunity to the four dengue serotypes — for instance, one recent candidate had lower efficacy
against serotype 2.
Researchers have
developed a candidate
vaccine against Ebola, one of the world's deadliest
viruses.
«
Vaccine against respiratory syncytial
virus shows promise in early trial: Researchers describe a new approach to
developing RSV
vaccines, reporting promising early results in young children.»
The reliably high percentage of those who
develop viremia following exposure to this challenge
virus is another advantage — when most or all volunteers
develop viremia or other signs of infection, clinical trials can enroll relatively small numbers of people but still achieve answers to such questions as whether a candidate
vaccine protects
against infection, she noted.
The flu
vaccine works by exposing the body to parts of inactivated flu from the three major different types of flu that infect humans, prompting the immune system to
develop antibodies
against these
viruses.
But for the first time we have evidence that a lethal
virus has
developed from
vaccines that were meant to protect
against it.
Kang's primary research focuses on designing and
developing effective
vaccines against viral diseases such as influenza
virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect
against disease because of the potential benefit in fighting these
viruses.
Although
vaccines are being
developed to fight dengue
virus, none are currently available that provide balanced protection
against all four dengue viral strains, or serotypes.
«Right now, there is no
vaccine to protect
against the H7N9
virus, and our findings could guide efforts to
develop effective
vaccine strategies,» Sasisekharan says.
He then became a principal investigator at the National Cancer Institute where he studied novel methods for
developing vaccines against tumors and
viruses.
Department researchers are
developing new
vaccines against these
viruses and in identifying small molecular weight compounds for use as antivirals.
While an effective
vaccine against the
virus has been
developed and will likely be approved, there are no drugs available to treat Ebola infections.
«In the future, [the findings] could apply to
vaccines that we hope will be
developed against generally lethal
viruses (e.g. HIV, Ebola), encouraging scientists to strive towards «perfect
vaccines» for them,» Michael Skinner, a virologist from Imperial College London who wasn't part of the study, told the Science Media Centre.
The focus of this application is to
develop an adenovirus - based
vaccine against rabies
virus that can provide rapid immunity following a single administration to achieve prophylactic status and as well as in response to a bioterrorism attack.
Scientists could be one step closer to
developing long - awaited
vaccines against viruses such as Zika, West Nile or HIV, thanks to research at Penn State College of Medicine.
Those antibodies could be used to
develop vaccines to protect
against Zika, as well as therapies to treat the
virus, according to the study, which was a collaboration between researchers at UNC's Gillings School of Global Public Health and the UNC School of Medicine.
One of the many complexities about
developing a successful dengue
vaccine, Metz explained, is that there are four serotypes of the
virus, which means researchers need to
develop a
vaccine that provides immunity
against all four serotypes.
Results from Sanjabi's study could also impact efforts to
develop vaccines against various
viruses.
A paper published today in PLOS Computational Biology has reported on the benefits that could be gained through
developing a universal
vaccine against the influenza
virus.
The team has
developed an EVD DNA
vaccine that is 100 percent protective in cynomolgus macaques
against lethal Ebola
virus challenge.
The two big ideas Ying Kai Chan is tackling in science — reducing the harmful side effects of gene therapy and
developing better
vaccines to protect
against viruses — might seem wildly different from one another.
Ever since Edward Jenner
developed the first successful
vaccine against the dreaded smallpox
virus, researchers have been riveted by the interplay between the body's defense mechanisms and pathogens staging an attack.
Scientists have also been making strides toward
developing a
vaccine to protect
against the Zika
virus and identifying molecules that can potentially lead to an anti-Zika drug.
«Ideally, horses will
develop antibodies
against the relevant
vaccine strain, resulting in a significant reduction of clinical disease and nasal shedding of the
virus,» points out Hancock.
First, while certainly anyone (ferret, person, or other animal) can have a reaction to a
vaccine, the incidence of
vaccine reactions has dramatically decreased since newer brands of
vaccine against both rabies and distemper
virus have been
developed for ferrets and since we started administering a Benadryl injection just prior to giving the shots.
At this time, it is also unknown whether the current CIV
vaccine,
developed to protect
against a different strain of the
virus (Influenza A H3N8), will be effective in preventing Influenza A H3N2.